In recent months, UnitedHealth Group has raised premiums by around 20–30%, updated its 2025 earnings guidance, and faced ...
UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.
Wondering if UnitedHealth Group is a bargain or a value trap at today’s price? Let us unpack what the market is really implying about this healthcare giant. After a rough stretch that has left the ...
UNH stock was a massive market beater for ages — until it wasn't.
UnitedHealth Group (NYSE: UNH) has outperformed the market over the past 15 years by 4.15% on an annualized basis producing an average annual return of 16.05%. Currently, UnitedHealth Group has a ...
Discover why UnitedHealth Group (UNH) is rated Buy, with margin recovery, earnings growth, and 154% upside potential.
The health insurance giant's stock got a big boost after Wall Street learned Berkshire Hathaway had invested in it.
We came across a bullish thesis on UnitedHealth Group Incorporated on Value investing subreddit by ashm1987. In this article, ...
Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...
By Tatiana Bautzer NEW YORK, Nov 30 (Reuters) - UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria Investments for $1 billion, ...
Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.